Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IndoProCaf (Difmetre®) Effervescent Tablets Effectiveness in Acute Treatment of Primary Headaches (Migraine and/or Episodic Tension-type Headache) and Patients' Satisfaction With the Treatment in Routine Clinical Practice in Ukraine and Kazakhstan

NCT02115269 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT02115269
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02115269 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IndoProCaf (Difmetre®) Effervescent Tablets Effectiveness in Acute Treatment of Primary Headaches (Migraine and/or Episodic Tension-type Headache) and Patients' Satisfaction With the Treatment in Routine Clinical Practice in Ukraine and Kazakhstan
Lead sponsor
Abbott
Phase
Observational
Overall status
Completed
Start date
June 30, 2014
Completion date
November 30, 2015
Enrollment
759 (actual)
Sites
30

Conditions

As the registry lists them; a condition with its own page is linked.

headache disorders, primary, migraine with aura, migraine without aura, tension-type headache